Literature DB >> 2428764

The radiosensitivity of cultured human and mouse keratinocytes.

E K Parkinson, W J Hume, C S Potten.   

Abstract

Clonogenic survival assays after gamma-radiation in vitro were performed on freshly isolated and subcultured keratinocytes from mouse skin, mouse tongue and human skin. Survival curves were constructed by fitting the data to a multi-target model of cell survival. When subcultured, keratinocytes from all sites produced survival curves which showed a reduced shoulder region and an increased D0 when compared with their freshly isolated counterparts. Freshly isolated human skin keratinocytes were more radiosensitive than mouse keratinocytes from either skin or tongue.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2428764     DOI: 10.1080/09553008614551111

Source DB:  PubMed          Journal:  Int J Radiat Biol Relat Stud Phys Chem Med        ISSN: 0020-7616


  4 in total

1.  The catalytic activity of the Src family kinases is required to disrupt cadherin-dependent cell-cell contacts.

Authors:  D W Owens; G W McLean; A W Wyke; C Paraskeva; E K Parkinson; M C Frame; V G Brunton
Journal:  Mol Biol Cell       Date:  2000-01       Impact factor: 4.138

Review 2.  [Genetic predisposition and radiation sensitivity of tumors].

Authors:  W Budach
Journal:  Strahlenther Onkol       Date:  1997-09       Impact factor: 3.621

3.  The NF-κB regulator Bcl-3 modulates inflammation during contact hypersensitivity reactions in radioresistant cells.

Authors:  Ilaria Tassi; Nimisha Rikhi; Estefania Claudio; Hongshan Wang; Wanhu Tang; Hye-Lin Ha; Sun Saret; Daniel H Kaplan; Ulrich Siebenlist
Journal:  Eur J Immunol       Date:  2015-02-12       Impact factor: 5.532

4.  Gene mutations and increased levels of p53 protein in human squamous cell carcinomas and their cell lines.

Authors:  J E Burns; M C Baird; L J Clark; P A Burns; K Edington; C Chapman; R Mitchell; G Robertson; D Soutar; E K Parkinson
Journal:  Br J Cancer       Date:  1993-06       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.